Capital Research Global Investors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,199,958
Closed -$481M 432
2019
Q3
$481M Buy
4,199,958
+842,441
+25% +$83.8M 0.16% 136
2019
Q2
$320M Buy
3,357,517
+1,456,117
+77% +$137M 0.1% 164
2019
Q1
$174M Sell
1,901,400
-185,948
-9% -$15.2M 0.06% 221
2018
Q4
$158M Sell
2,087,348
-960,434
-32% -$70.7M 0.06% 222
2018
Q3
$244M Sell
3,047,782
-620,455
-17% -$57.8M 0.07% 213
2018
Q2
$364M Sell
3,668,237
-307,671
-8% -$26.6M 0.1% 175
2018
Q1
$322M Buy
3,975,908
+694,944
+21% +$56.2M 0.09% 182
2017
Q4
$258M Buy
3,280,964
+3,925
+0.1% +$326K 0.08% 202
2017
Q3
$302M Buy
3,277,039
+12,356
+0.4% +$1.19M 0.09% 181
2017
Q2
$369M Buy
3,264,683
+7,835
+0.2% +$876K 0.12% 165
2017
Q1
$326M Buy
3,256,848
+352
+0% +$37.6K 0.1% 181
2016
Q4
$350M Buy
3,256,496
+130,611
+4% +$15.3M 0.11% 174
2016
Q3
$389M Buy
3,125,885
+94,231
+3% +$11.1M 0.13% 159
2016
Q2
$322M Buy
3,031,654
+904,377
+43% +$105M 0.11% 169
2016
Q1
$244M Buy
2,127,277
+1,802,277
+555% +$211M 0.08% 203
2015
Q4
$46.3M Buy
+325,000
New +$37.5M 0.02% 334

Other funds holding CBPO

Capital Research Global Investors's CBPO Position: Q4 2019 in Review

Capital Research Global Investors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2019, closing a stake of 4,199,958 shares — an estimated $481M sold.

Capital Research Global Investors first reported a position in CBPO in Q4 2015 and held it in 16 quarters. The position peaked at $481M in Q3 2019. 87 funds tracked by Wall St. Rank hold CBPO as of Q4 2019.

  • Capital Research Global Investors reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2019 after selling out during the quarter.
  • Capital Research Global Investors sold 4,199,958 China Biologic Products Holdings, Inc. shares in Q4 2019, an estimated $481M.
  • Capital Research Global Investors first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 16 quarters.
  • Capital Research Global Investors's China Biologic Products Holdings, Inc. position peaked at $481M in Q3 2019.
  • 87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2019.

Based on Capital Research Global Investors's 13F filing for Q4 2019, filed 18 Feb 2020.